Global Antiretroviral Agent Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Page: 99

Published Date: 26 Nov 2021

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Antiretroviral Agent market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Antiretroviral Agent size is estimated to be  million in 2021 from USD  million in 2020, with a change of  % between 2020 and 2021. The global Antiretroviral Agent market size is expected to grow at a CAGR of  % for the next five years.

Market segmentation
Antiretroviral Agent market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Nucleoside Reverse Transcriptase Inhibitors
    Protease Inhibitors
    HIV Integrase Strand Transfer Inhibitors
    Non-Nucleoside Reverse Transcriptase Inhibitors
    Entry Inhibitors—CCR5 Co-Receptor Antagonist
    Fusion Inhibitors
    Others

Market segment by Application can be divided into
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies
    Others

The key market players for global Antiretroviral Agent market are listed below:
    ViiV Healthcare
    Gilead Sciences
    GlaxoSmithKline
    Merck Sharp and Dohme
    Bristol-Myers Squibb
    Janssen Pharmaceuticals
    Pfizer
    Boehringer Ingelheim
    AbbVie
    Genentech
    Mylan

Market segment by Region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Antiretroviral Agent product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Antiretroviral Agent, with price, sales, revenue and global market share of Antiretroviral Agent from 2019 to 2021.
Chapter 3, the Antiretroviral Agent competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antiretroviral Agent breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Antiretroviral Agent market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Antiretroviral Agent sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Antiretroviral Agent Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Antiretroviral Agent Revenue by Type: 2019 Versus 2021 Versus 2026
        1.2.2 Nucleoside Reverse Transcriptase Inhibitors
        1.2.3 Protease Inhibitors
        1.2.4 HIV Integrase Strand Transfer Inhibitors
        1.2.5 Non-Nucleoside Reverse Transcriptase Inhibitors
        1.2.6 Entry Inhibitors—CCR5 Co-Receptor Antagonist
        1.2.7 Fusion Inhibitors
        1.2.8 Others
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Antiretroviral Agent Revenue by Application: 2019 Versus 2021 Versus 2026
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Online Pharmacies
        1.3.5 Others
    1.4 Global Antiretroviral Agent Market Size & Forecast
        1.4.1 Global Antiretroviral Agent Sales in Value (2016-2026))
        1.4.2 Global Antiretroviral Agent Sales in Volume (2016-2026)
        1.4.3 Global Antiretroviral Agent Price by Type (2016-2026) & (US$/Unit)
    1.5 Global Antiretroviral Agent Production Capacity Analysis
        1.5.1 Global Antiretroviral Agent Total Production Capacity (2016-2026)
        1.5.2 Global Antiretroviral Agent Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Antiretroviral Agent Market Drivers
        1.6.2 Antiretroviral Agent Market Restraints
        1.6.3 Antiretroviral Agent Trends Analysis

2 Manufacturers Profiles
    2.1 ViiV Healthcare
        2.1.1 ViiV Healthcare Details
        2.1.2 ViiV Healthcare Major Business
        2.1.3 ViiV Healthcare Antiretroviral Agent Product and Services
        2.1.4 ViiV Healthcare Antiretroviral Agent Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.2 Gilead Sciences
        2.2.1 Gilead Sciences Details
        2.2.2 Gilead Sciences Major Business
        2.2.3 Gilead Sciences Antiretroviral Agent Product and Services
        2.2.4 Gilead Sciences Antiretroviral Agent Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.3 GlaxoSmithKline
        2.3.1 GlaxoSmithKline Details
        2.3.2 GlaxoSmithKline Major Business
        2.3.3 GlaxoSmithKline Antiretroviral Agent Product and Services
        2.3.4 GlaxoSmithKline Antiretroviral Agent Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.4 Merck Sharp and Dohme
        2.4.1 Merck Sharp and Dohme Details
        2.4.2 Merck Sharp and Dohme Major Business
        2.4.3 Merck Sharp and Dohme Antiretroviral Agent Product and Services
        2.4.4 Merck Sharp and Dohme Antiretroviral Agent Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.5 Bristol-Myers Squibb
        2.5.1 Bristol-Myers Squibb Details
        2.5.2 Bristol-Myers Squibb Major Business
        2.5.3 Bristol-Myers Squibb Antiretroviral Agent Product and Services
        2.5.4 Bristol-Myers Squibb Antiretroviral Agent Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.6 Janssen Pharmaceuticals
        2.6.1 Janssen Pharmaceuticals Details
        2.6.2 Janssen Pharmaceuticals Major Business
        2.6.3 Janssen Pharmaceuticals Antiretroviral Agent Product and Services
        2.6.4 Janssen Pharmaceuticals Antiretroviral Agent Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.7 Pfizer
        2.7.1 Pfizer Details
        2.7.2 Pfizer Major Business
        2.7.3 Pfizer Antiretroviral Agent Product and Services
        2.7.4 Pfizer Antiretroviral Agent Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.8 Boehringer Ingelheim
        2.8.1 Boehringer Ingelheim Details
        2.8.2 Boehringer Ingelheim Major Business
        2.8.3 Boehringer Ingelheim Antiretroviral Agent Product and Services
        2.8.4 Boehringer Ingelheim Antiretroviral Agent Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.9 AbbVie
        2.9.1 AbbVie Details
        2.9.2 AbbVie Major Business
        2.9.3 AbbVie Antiretroviral Agent Product and Services
        2.9.4 AbbVie Antiretroviral Agent Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.10 Genentech
        2.10.1 Genentech Details
        2.10.2 Genentech Major Business
        2.10.3 Genentech Antiretroviral Agent Product and Services
        2.10.4 Genentech Antiretroviral Agent Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.11 Mylan
        2.11.1 Mylan Details
        2.11.2 Mylan Major Business
        2.11.3 Mylan Antiretroviral Agent Product and Services
        2.11.4 Mylan Antiretroviral Agent Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Antiretroviral Agent Sales by Manufacturer
    3.1 Global Antiretroviral Agent Sales in Volume by Manufacturer (2019-2021e)
    3.2 Global Antiretroviral Agent Revenue by Manufacturer (2019-2021e)
    3.3 Key Manufacturer Market Position in Antiretroviral Agent
    3.4 Market Concentration Rate
        3.4.1 Top 3 Antiretroviral Agent Manufacturer Market Share
        3.4.2 Top 6 Antiretroviral Agent Manufacturer Market Share
    3.5 Global Antiretroviral Agent Production Capacity by Company
    3.6 Manufacturer by Geography: Head Office and Antiretroviral Agent Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Antiretroviral Agent Market Size by Region
        4.1.1 Global Antiretroviral Agent Sales in Volume by Region (2016-2026)
        4.1.2 Global Antiretroviral Agent Revenue by Region (2016-2026)
    4.2 North America Antiretroviral Agent Revenue (2016-2026)
    4.3 Europe Antiretroviral Agent Revenue (2016-2026)
    4.4 Asia-Pacific Antiretroviral Agent Revenue (2016-2026)
    4.5 South America Antiretroviral Agent Revenue (2016-2026)
    4.6 Middle East and Africa Antiretroviral Agent Revenue (2016-2026)

5 Market Segment by Type
    5.1 Global Antiretroviral Agent Sales in Volume by Type (2016-2026)
    5.2 Global Antiretroviral Agent Revenue by Type (2016-2026)
    5.3 Global Antiretroviral Agent Price by Type (2016-2026)

6 Market Segment by Application
    6.1 Global Antiretroviral Agent Sales in Volume by Application (2016-2026)
    6.2 Global Antiretroviral Agent Revenue by Application (2016-2026)
    6.3 Global Antiretroviral Agent Price by Application (2016-2026)

7 North America by Country, by Type, and by Application
    7.1 North America Antiretroviral Agent Sales by Type (2016-2026)
    7.2 North America Antiretroviral Agent Sales by Application (2016-2026)
    7.3 North America Antiretroviral Agent Market Size by Country
        7.3.1 North America Antiretroviral Agent Sales in Volume by Country (2016-2026)
        7.3.2 North America Antiretroviral Agent Revenue by Country (2016-2026)
        7.3.3 United States Market Size and Forecast (2016-2026)
        7.3.4 Canada Market Size and Forecast (2016-2026)
        7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application
    8.1 Europe Antiretroviral Agent Sales by Type (2016-2026)
    8.2 Europe Antiretroviral Agent Sales by Application (2016-2026)
    8.3 Europe Antiretroviral Agent Market Size by Country
        8.3.1 Europe Antiretroviral Agent Sales in Volume by Country (2016-2026)
        8.3.2 Europe Antiretroviral Agent Revenue by Country (2016-2026)
        8.3.3 Germany Market Size and Forecast (2016-2026)
        8.3.4 France Market Size and Forecast (2016-2026)
        8.3.5 United Kingdom Market Size and Forecast (2016-2026)
        8.3.6 Russia Market Size and Forecast (2016-2026)
        8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application
    9.1 Asia-Pacific Antiretroviral Agent Sales by Type (2016-2026)
    9.2 Asia-Pacific Antiretroviral Agent Sales by Application (2016-2026)
    9.3 Asia-Pacific Antiretroviral Agent Market Size by Region
        9.3.1 Asia-Pacific Antiretroviral Agent Sales in Volume by Region (2016-2026)
        9.3.2 Asia-Pacific Antiretroviral Agent Revenue by Region (2016-2026)
        9.3.3 China Market Size and Forecast (2016-2026)
        9.3.4 Japan Market Size and Forecast (2016-2026)
        9.3.5 Korea Market Size and Forecast (2016-2026)
        9.3.6 India Market Size and Forecast (2016-2026)
        9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
        9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application
    10.1 South America Antiretroviral Agent Sales by Type (2016-2026)
    10.2 South America Antiretroviral Agent Sales by Application (2016-2026)
    10.3 South America Antiretroviral Agent Market Size by Country
        10.3.1 South America Antiretroviral Agent Sales in Volume by Country (2016-2026)
        10.3.2 South America Antiretroviral Agent Revenue by Country (2016-2026)
        10.3.3 Brazil Market Size and Forecast (2016-2026)
        10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Antiretroviral Agent Sales by Type (2016-2026)
    11.2 Middle East & Africa Antiretroviral Agent Sales by Application (2016-2026)
    11.3 Middle East & Africa Antiretroviral Agent Market Size by Country
        11.3.1 Middle East & Africa Antiretroviral Agent Sales in Volume by Country (2016-2026)
        11.3.2 Middle East & Africa Antiretroviral Agent Revenue by Country (2016-2026)
        11.3.3 Turkey Market Size and Forecast (2016-2026)
        11.3.4 Egypt Market Size and Forecast (2016-2026)
        11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
        11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers
    12.1 Sales Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
    12.2 Antiretroviral Agent Typical Distributors
    12.3 Antiretroviral Agent Typical Customers

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Antiretroviral Agent Revenue by Type, (USD Million), 2021-2026
    Table 2. Global Antiretroviral Agent Revenue by Application, (USD Million), 2021-2026
    Table 3. ViiV Healthcare Basic Information, Manufacturing Base and Competitors
    Table 4. ViiV Healthcare Major Business
    Table 5. ViiV Healthcare Antiretroviral Agent Product and Services
    Table 6. ViiV Healthcare Antiretroviral Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 7. Gilead Sciences Basic Information, Manufacturing Base and Competitors
    Table 8. Gilead Sciences Major Business
    Table 9. Gilead Sciences Antiretroviral Agent Product and Services
    Table 10. Gilead Sciences Antiretroviral Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 11. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
    Table 12. GlaxoSmithKline Major Business
    Table 13. GlaxoSmithKline Antiretroviral Agent Product and Services
    Table 14. GlaxoSmithKline Antiretroviral Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 15. Merck Sharp and Dohme Basic Information, Manufacturing Base and Competitors
    Table 16. Merck Sharp and Dohme Major Business
    Table 17. Merck Sharp and Dohme Antiretroviral Agent Product and Services
    Table 18. Merck Sharp and Dohme Antiretroviral Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 19. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
    Table 20. Bristol-Myers Squibb Major Business
    Table 21. Bristol-Myers Squibb Antiretroviral Agent Product and Services
    Table 22. Bristol-Myers Squibb Antiretroviral Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 23. Janssen Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 24. Janssen Pharmaceuticals Major Business
    Table 25. Janssen Pharmaceuticals Antiretroviral Agent Product and Services
    Table 26. Janssen Pharmaceuticals Antiretroviral Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 27. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 28. Pfizer Major Business
    Table 29. Pfizer Antiretroviral Agent Product and Services
    Table 30. Pfizer Antiretroviral Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 31. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
    Table 32. Boehringer Ingelheim Major Business
    Table 33. Boehringer Ingelheim Antiretroviral Agent Product and Services
    Table 34. Boehringer Ingelheim Antiretroviral Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 35. AbbVie Basic Information, Manufacturing Base and Competitors
    Table 36. AbbVie Major Business
    Table 37. AbbVie Antiretroviral Agent Product and Services
    Table 38. AbbVie Antiretroviral Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 39. Genentech Basic Information, Manufacturing Base and Competitors
    Table 40. Genentech Major Business
    Table 41. Genentech Antiretroviral Agent Product and Services
    Table 42. Genentech Antiretroviral Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 43. Mylan Basic Information, Manufacturing Base and Competitors
    Table 44. Mylan Major Business
    Table 45. Mylan Antiretroviral Agent Product and Services
    Table 46. Mylan Antiretroviral Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 47. Global Antiretroviral Agent Sales by Manufacturer (2019-2021e) & (K Units)
    Table 48. Global Antiretroviral Agent Revenue by Manufacturer (2019-2021e) & (USD Million)
    Table 49. Market Position of Manufacturers in Antiretroviral Agent, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
    Table 50. Global Antiretroviral Agent Production Capacity by Company, (K Units): 2020 VS 2021
    Table 51. Head Office and Antiretroviral Agent Production Site of Key Manufacturer
    Table 52. Antiretroviral Agent New Entrant and Capacity Expansion Plans
    Table 53. Antiretroviral Agent Mergers & Acquisitions in the Past Five Years
    Table 54. Global Antiretroviral Agent Sales by Region (2016-2021e) & (K Units)
    Table 55. Global Antiretroviral Agent Sales by Region (2021-2026) & (K Units)
    Table 56. Global Antiretroviral Agent Revenue by Region (2016-2021e) & (USD Million)
    Table 57. Global Antiretroviral Agent Revenue by Region (2021-2026) & (USD Million)
    Table 58. Global Antiretroviral Agent Sales by Type (2016-2021e) & (K Units)
    Table 59. Global Antiretroviral Agent Sales by Type (2021-2026) & (K Units)
    Table 60. Global Antiretroviral Agent Revenue by Type (2016-2021e) & (USD Million)
    Table 61. Global Antiretroviral Agent Revenue by Type (2021-2026) & (USD Million)
    Table 62. Global Antiretroviral Agent Price by Type (2016-2021e) & (US$/Unit)
    Table 63. Global Antiretroviral Agent Price by Type (2021-2026) & (US$/Unit)
    Table 64. Global Antiretroviral Agent Sales by Application (2016-2021e) & (K Units)
    Table 65. Global Antiretroviral Agent Sales by Application (2021-2026) & (K Units)
    Table 66. Global Antiretroviral Agent Revenue by Application (2016-2021e) & (USD Million)
    Table 67. Global Antiretroviral Agent Revenue by Application (2021-2026) & (USD Million)
    Table 68. Global Antiretroviral Agent Price by Application (2016-2021e) & (US$/Unit)
    Table 69. Global Antiretroviral Agent Price by Application (2021-2026) & (US$/Unit)
    Table 70. North America Antiretroviral Agent Sales by Country (2016-2021e) & (K Units)
    Table 71. North America Antiretroviral Agent Sales by Country (2021-2026) & (K Units)
    Table 72. North America Antiretroviral Agent Revenue by Country (2016-2021e) & (USD Million)
    Table 73. North America Antiretroviral Agent Revenue by Country (2021-2026) & (USD Million)
    Table 74. North America Antiretroviral Agent Sales by Type (2016-2021e) & (K Units)
    Table 75. North America Antiretroviral Agent Sales by Type (2021-2026) & (K Units)
    Table 76. North America Antiretroviral Agent Sales by Application (2016-2021e) & (K Units)
    Table 77. North America Antiretroviral Agent Sales by Application (2021-2026) & (K Units)
    Table 78. Europe Antiretroviral Agent Sales by Country (2016-2021e) & (K Units)
    Table 79. Europe Antiretroviral Agent Sales by Country (2021-2026) & (K Units)
    Table 80. Europe Antiretroviral Agent Revenue by Country (2016-2021e) & (USD Million)
    Table 81. Europe Antiretroviral Agent Revenue by Country (2021-2026) & (USD Million)
    Table 82. Europe Antiretroviral Agent Sales by Type (2016-2021e) & (K Units)
    Table 83. Europe Antiretroviral Agent Sales by Type (2021-2026) & (K Units)
    Table 84. Europe Antiretroviral Agent Sales by Application (2016-2021e) & (K Units)
    Table 85. Europe Antiretroviral Agent Sales by Application (2021-2026) & (K Units)
    Table 86. Asia-Pacific Antiretroviral Agent Sales by Region (2016-2021e) & (K Units)
    Table 87. Asia-Pacific Antiretroviral Agent Sales by Region (2021-2026) & (K Units)
    Table 88. Asia-Pacific Antiretroviral Agent Revenue by Region (2016-2021e) & (USD Million)
    Table 89. Asia-Pacific Antiretroviral Agent Revenue by Region (2021-2026) & (USD Million)
    Table 90. Asia-Pacific Antiretroviral Agent Sales by Type (2016-2021e) & (K Units)
    Table 91. Asia-Pacific Antiretroviral Agent Sales by Type (2021-2026) & (K Units)
    Table 92. Asia-Pacific Antiretroviral Agent Sales by Application (2016-2021e) & (K Units)
    Table 93. Asia-Pacific Antiretroviral Agent Sales by Application (2021-2026) & (K Units)
    Table 94. South America Antiretroviral Agent Sales by Country (2016-2021e) & (K Units)
    Table 95. South America Antiretroviral Agent Sales by Country (2021-2026) & (K Units)
    Table 96. South America Antiretroviral Agent Revenue by Country (2016-2021e) & (USD Million)
    Table 97. South America Antiretroviral Agent Revenue by Country (2021-2026) & (USD Million)
    Table 98. South America Antiretroviral Agent Sales by Type (2016-2021e) & (K Units)
    Table 99. South America Antiretroviral Agent Sales by Type (2021-2026) & (K Units)
    Table 100. South America Antiretroviral Agent Sales by Application (2016-2021e) & (K Units)
    Table 101. South America Antiretroviral Agent Sales by Application (2021-2026) & (K Units)
    Table 102. Middle East & Africa Antiretroviral Agent Sales by Country (2016-2021e) & (K Units)
    Table 103. Middle East & Africa Antiretroviral Agent Sales by Country (2021-2026) & (K Units)
    Table 104. Middle East & Africa Antiretroviral Agent Revenue by Country (2016-2021e) & (USD Million)
    Table 105. Middle East & Africa Antiretroviral Agent Revenue by Country (2021-2026) & (USD Million)
    Table 106. Middle East & Africa Antiretroviral Agent Sales by Type (2016-2021e) & (K Units)
    Table 107. Middle East & Africa Antiretroviral Agent Sales by Type (2021-2026) & (K Units)
    Table 108. Middle East & Africa Antiretroviral Agent Sales by Application (2016-2021e) & (K Units)
    Table 109. Middle East & Africa Antiretroviral Agent Sales by Application (2021-2026) & (K Units)
    Table 110. Direct Channel Pros & Cons
    Table 111. Indirect Channel Pros & Cons
    Table 112. Antiretroviral Agent Typical Distributors
    Table 113. Antiretroviral Agent Typical Customers
List of Figures
    Figure 1. Antiretroviral Agent Picture
    Figure 2. Global Antiretroviral Agent Sales Market Share by Type in 2020
    Figure 3. Nucleoside Reverse Transcriptase Inhibitors
    Figure 4. Protease Inhibitors
    Figure 5. HIV Integrase Strand Transfer Inhibitors
    Figure 6. Non-Nucleoside Reverse Transcriptase Inhibitors
    Figure 7. Entry Inhibitors—CCR5 Co-Receptor Antagonist
    Figure 8. Fusion Inhibitors
    Figure 9. Others
    Figure 10. Global Antiretroviral Agent Sales Market Share by Application in 2020
    Figure 11. Hospital Pharmacies
    Figure 12. Retail Pharmacies
    Figure 13. Online Pharmacies
    Figure 14. Others
    Figure 15. Global Antiretroviral Agent Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
    Figure 16. Global Antiretroviral Agent Market Size and Forecast (2016-2026) & (USD Million)
    Figure 17. Global Antiretroviral Agent Sales (2016-2026) & (K Units)
    Figure 18. Global Antiretroviral Agent Price by Type (2016-2026) & (US$/Unit)
    Figure 19. Global Antiretroviral Agent Production Capacity (2016-2026) & (K Units)
    Figure 20. Global Antiretroviral Agent Production Capacity by Geographic Region: 2020 VS 2021
    Figure 21. Antiretroviral Agent Market Drivers
    Figure 22. Antiretroviral Agent Market Restraints
    Figure 23. Antiretroviral Agent Market Trends
    Figure 24. Global Antiretroviral Agent Sales Market Share by Manufacturer in 2020
    Figure 25. Global Antiretroviral Agent Revenue Market Share by Manufacturer in 2020
    Figure 26. Antiretroviral Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    Figure 27. Top 3 Antiretroviral Agent Manufacturer (Revenue) Market Share in 2020
    Figure 28. Top 6 Antiretroviral Agent Manufacturer (Revenue) Market Share in 2020
    Figure 29. Global Antiretroviral Agent Sales Market Share by Region (2016-2026)
    Figure 30. Global Antiretroviral Agent Revenue Market Share by Region (2016-2026)
    Figure 31. North America Antiretroviral Agent Revenue (2016-2026) & (USD Million)
    Figure 32. Europe Antiretroviral Agent Revenue (2016-2026) & (USD Million)
    Figure 33. Asia-Pacific Antiretroviral Agent Revenue (2016-2026) & (USD Million)
    Figure 34. South America Antiretroviral Agent Revenue (2016-2026) & (USD Million)
    Figure 35. Middle East & Africa Antiretroviral Agent Revenue (2016-2026) & (USD Million)
    Figure 36. Global Antiretroviral Agent Sales Market Share by Type (2016-2026)
    Figure 37. Global Antiretroviral Agent Revenue Market Share by Type (2016-2026)
    Figure 38. Global Antiretroviral Agent Price by Type (2016-2026) & (US$/Unit)
    Figure 39. Global Antiretroviral Agent Sales Market Share by Application (2016-2026)
    Figure 40. Global Antiretroviral Agent Revenue Market Share by Application (2016-2026)
    Figure 41. Global Antiretroviral Agent Price by Application (2016-2026) & (US$/Unit)
    Figure 42. North America Antiretroviral Agent Sales Market Share by Type (2016-2026)
    Figure 43. North America Antiretroviral Agent Sales Market Share by Application (2016-2026)
    Figure 44. North America Antiretroviral Agent Sales Market Share by Country (2016-2026)
    Figure 45. North America Antiretroviral Agent Revenue Market Share by Country (2016-2026)
    Figure 46. United States Antiretroviral Agent Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 47. Canada Antiretroviral Agent Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 48. Mexico Antiretroviral Agent Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 49. Europe Antiretroviral Agent Sales Market Share by Type (2016-2026)
    Figure 50. Europe Antiretroviral Agent Sales Market Share by Application (2016-2026)
    Figure 51. Europe Antiretroviral Agent Sales Market Share by Country (2016-2026)
    Figure 52. Europe Antiretroviral Agent Revenue Market Share by Country (2016-2026)
    Figure 53. Germany Antiretroviral Agent Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 54. France Antiretroviral Agent Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 55. United Kingdom Antiretroviral Agent Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 56. Russia Antiretroviral Agent Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 57. Italy Antiretroviral Agent Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 58. Asia-Pacific Antiretroviral Agent Sales Market Share by Region (2016-2026)
    Figure 59. Asia-Pacific Antiretroviral Agent Sales Market Share by Application (2016-2026)
    Figure 60. Asia-Pacific Antiretroviral Agent Sales Market Share by Region (2016-2026)
    Figure 61. Asia-Pacific Antiretroviral Agent Revenue Market Share by Region (2016-2026)
    Figure 62. China Antiretroviral Agent Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 63. Japan Antiretroviral Agent Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 64. Korea Antiretroviral Agent Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 65. India Antiretroviral Agent Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 66. Southeast Asia Antiretroviral Agent Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 67. Australia Antiretroviral Agent Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 68. South America Antiretroviral Agent Sales Market Share by Type (2016-2026)
    Figure 69. South America Antiretroviral Agent Sales Market Share by Application (2016-2026)
    Figure 70. South America Antiretroviral Agent Sales Market Share by Country (2016-2026)
    Figure 71. South America Antiretroviral Agent Revenue Market Share by Country (2016-2026)
    Figure 72. Brazil Antiretroviral Agent Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 73. Argentina Antiretroviral Agent Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 74. Middle East & Africa Antiretroviral Agent Sales Market Share by Type (2016-2026)
    Figure 75. Middle East & Africa Antiretroviral Agent Sales Market Share by Application (2016-2026)
    Figure 76. Middle East & Africa Antiretroviral Agent Sales Market Share by Country (2016-2026)
    Figure 77. Middle East & Africa Antiretroviral Agent Revenue Market Share by Country (2016-2026)
    Figure 78. Turkey Antiretroviral Agent Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 79. Egypt Antiretroviral Agent Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 80. Saudi Arabia Antiretroviral Agent Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 81. South Africa Antiretroviral Agent Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 82. Sales Channel: Direct Channel vs Indirect Channel
    Figure 83. Methodology
    Figure 84. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

ViiV Healthcare
Gilead Sciences
GlaxoSmithKline
Merck Sharp and Dohme
Bristol-Myers Squibb
Janssen Pharmaceuticals
Pfizer
Boehringer Ingelheim
AbbVie
Genentech
Mylan

Related Reports

Global Antiretroviral Agent Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Antiretroviral Agent Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 26 Feb 2023

date Pharma & Healthcare

The clinical use of antiretroviral agents involves a pathogenesis-based, combination treatment approach. Increase in the number of chronic diseases, HIV infections will lead to more medicinal development. The surge for anti-resistant medicines has been in demand. In addition as monoclonal antibodies demand increases, the growth for the antiretroviral (ARV) agents market will spike its rate, demand in personalized medicines has increased bio production, accelerating antiretroviral (ARV) demand.

Global Antiretroviral Agent Supply, Demand and Key Producers, 2023-2029

Global Antiretroviral Agent Supply, Demand and Key Producers, 2023-2029

date 20 Jan 2023

date Pharma & Healthcare

The global Antiretroviral Agent market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Antiretroviral Agent Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Antiretroviral Agent Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Antiretroviral Agent market size was valued at USD 49750 million in 2023 and is forecast to a readjusted size of USD 62660 million by 2030 with a CAGR of 3.3% during review period.

Global Antiretroviral Agent Supply, Demand and Key Producers, 2024-2030

Global Antiretroviral Agent Supply, Demand and Key Producers, 2024-2030

date 14 Feb 2024

date Pharma & Healthcare

The global Antiretroviral Agent market size is expected to reach $ 62660 million by 2030, rising at a market growth of 3.3% CAGR during the forecast period (2024-2030).

Product Tags

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>